DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» FOLFIRI
FOLFIRI
Regimen Reference Order – GAST – FOLFIRI
Download
Situation De La Chimiothérapie Des Cancers Rapport 2012
Or Irinotecan-Based Chemotherapy After Curative Resection of Synchronous Liver Metastases from Colorectal Cancer
Advances in Targeted Therapies for Metastatic Colorectal Cancer
FOLFIRI (Irinotecan / Modified De Gramont)
Download FOLFIRI Chemotherapy
For Health Professionals Who Care for Cancer Patients February 2007 Website Access At
Combination of Small-Molecule Kinase Inhibitors and Irinotecan in Cancer Clinical Trials: Efficacy and Safety Considerations
View PDF of HOPA News, Vol. 17, No. 4
Negative Change Add Inclusion Criteria
Hypertension Secondary to Anti-Angiogenic Therapy: Experience with Bevacizumab
Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease
Trailblazing Strategies for Cancer Treatment
Metastatic Colorectal Cancer
An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma
FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (Mcrc) in Current Clinical Practice: OZONE Study
Master Trial List June 2021 ***New & Reopened Trials Highlighted in Green!***
Top View
Understanding PI3K Signalling in Colorectal Cancer: from Function to Therapy
GIFFIRB Protocol
Modifying Chemotherapy for the Older Patient
In Advanced Colorectal Cancer
New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer
Managing Side Effects of Cancer Patients Treated with Immunotherapy Brianna Hoffner, MSN, RN, ANP-BC, AOCNP® Lead Advanced Practice Provider University of Colorado
And Irinotecan (FOLFIRI)
EMETOGENICITY of CHEMOTHERAPY REGIMENS Version 2019
The London School of Economics and Political Science Cancer Medicines
FOLFIRI Regimen: an Effective Second-Line Chemotherapy After Failure of Etoposide–Platinum Combination in Patients with Neuroendocrine Carcinomas Grade 3
Targeted Strategies in the Treatment of Metastatic Colon Cancer
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors
215.Full.Pdf
Drug-Drug Interactions in Patients Treated with Anti-Cancer Agents
Prospective Phase II Trial of Second-Line FOLFIRI in Patients with Advanced Colorectal Cancer Including Analysis of UGT1A1 Polymorphisms: FLIGHT 2 Study
Effect of 5-Fluorouracil on Translational Regulation in Colorectal Cancer Cells Zeina Bash Imam
XELIRI Or FOLFIRI As Salvage Therapy in Advanced Pancreatic Cancer
Bevacizumab with FOLFIRI Or XELIRI in the First-Line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry